Patents by Inventor Jacques Noel

Jacques Noel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220379009
    Abstract: In general, systems for administering a dmg are provided. In an exemplary embodiment, a dmg administration system includes a dmg administration device configured to communicate with a computer system and at least one sensor configured to obtain sensor data and communicate the sensor data to the drug administration device. The dmg administration device is configured to utilize a first drug dosing scheme when a drug is delivered to a patient, determine a second drug dosing scheme for delivering a drug to the patient dependent on dosing data from the computer system and sensor data collected by the sensor during and/or after the delivery of the first drug according to the first drug dosing scheme, and utilize the second drug dosing scheme when the drug is delivered to the patient.
    Type: Application
    Filed: September 24, 2020
    Publication date: December 1, 2022
    Inventors: Francesco N. ALBERTINI, Gregory J. BAKOS, Anthony R. DIUBALDI, Jason L. HARRIS, Michael HUTCHINSON, Wouter Jacques Noel LEQUIEU, Frederick E. SHELTON, IV, George SZABO, Steven M. VESOLE
  • Publication number: 20220361758
    Abstract: In general, drug administration devices configured to communicate with networks and external devices are provided. In an exemplary embodiment, a drug administration device is configured to adjust an operational parameter of the drug administration device based on a data packet formed from drug administration data ancillary data received from networks and/or external devices. In another example embodiment, a drug administration device is configured to scan for and establish communications with at least one external device. In another example embodiment, a method includes assessing whether to update a control program on a drug administration device from a network or external device. In another example embodiment, a system includes a first drug administration device configured to communicate with a second drug administration device to optimize a drug treatment.
    Type: Application
    Filed: September 24, 2020
    Publication date: November 17, 2022
    Inventors: Francesco N. ALBERTINI, Gregory J. BAKOS, Jeffrey DANIEL, Anthony R. DIUBALDI, James A. FLEMING, Jason L. HARRIS, Kevin L. HOUSER, Emma Louise HUBERT, Michael HUTCHINSON, David KALIKHMAN, Monica A. KAPIL, Wouter Jacques Noel LEQUIEU, David RAMOS, Ian SCRIMGEOUR, Frederick E. SHELTON, IV, Jaskaran SINGH, Steven M. VESOLE, Jingli WANG, Hong YAN
  • Publication number: 20220336074
    Abstract: In general, interconnection of drug administration systems is provided. In an exemplary embodiment, a drug administration device and a remotely located server can establish a unique key for wireless communication between the device and the server. The drug administration device can be configured to sense information relating to at least one of the device and a drug and can be configured to anonymize data indicative of the sensed information using the key stored in memory of the device. The drug administration device can also be configured to use the key in decrypting data received from the server.
    Type: Application
    Filed: September 24, 2020
    Publication date: October 20, 2022
    Inventors: Gregory J. BAKOS, Michael A. BARATTA, Yueheng DOU, Jason L. HARRIS, Emma Louise HUBERT, Monica A. KAPIL, Peter KRULEVITCH, Wouter Jacques Noel LEQUIEU, Dolores PEREZ, Whitney PHILLIPS, Frederick E. SHELTON, Hong YAN
  • Publication number: 20220336076
    Abstract: The present disclosure relates to drug administration. In an exemplary embodiment, a system can include a drug administration device configured to dispense a drug to a patient, a monitoring device configured to log a delivery event of drug delivery from the drug administration device into the patient, and a sensor configured to sense a patient parameter following delivery of the drug into the patient. In another exemplary embodiment, a drug administration device can include a drug holder configured to hold a drug, a dispensing mechanism configured to dispense the drug, and a sensor configured to sense a patient parameter, and the drug administration device can be configured to locally activate the drug at a target location in the patient. In another exemplary embodiment, methods, devices, and systems are provided to assess when operation of a drug dispensing mechanism is complete and to confirm whether drug administration was successful.
    Type: Application
    Filed: September 24, 2020
    Publication date: October 20, 2022
    Inventors: Francesco N. ALBERTINI, Gregory J. BAKOS, Anthony R. DIUBALDI, Jason L. HARRIS, Emma Louise HUBERT, Michael HUTCHINSON, David KALIKHMAN, Monica A. KAPIL, Peter KRULEVITCH, Wouter Jacques Noel LEQUIEU, Frederick E. SHELTON, IV, Jaskaran SINGH, George SZABO, Steven M. VESOLE, Jingli WANG
  • Publication number: 20220323695
    Abstract: Drug delivery systems and methods are provided for monitoring and/or tracking exposure of a drug to one or more conditions that can affect performance of the drug.
    Type: Application
    Filed: September 24, 2020
    Publication date: October 13, 2022
    Inventors: Francesco N. ALBERTINI, Gregory J. BAKOS, Anthony R. DIUBALDI, Jason L. HARRIS, Emma Louise HUBERT, Michael HUTCHINSON, Monica A. KAPIL, Peter KRULEVITCH, Chaley John LARSON, Wouter Jacques Noel LEQUIEU, Frederick E. SHELTON, IV, Michael J. VENDELY, Steven M. VESOLE
  • Patent number: 10516662
    Abstract: A method of authenticating the legitimacy of a request for a resource from a resource provider by a user, including providing an authentication process in which a resource provider message is received and de-assembled, the integrity of the user request message is confirmed, a result indicator as to the legitimacy of the resource provider message is created by performing two or more authenticity checks, and an authentication result is sent.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: December 24, 2019
    Assignee: Robojar Pty Ltd
    Inventor: Jacques Noel Marc Chester
  • Publication number: 20180124043
    Abstract: A method of authenticating the legitimacy of a request for a resource from a resource provider by a user, including providing an authentication process in which a resource provider message is received and de-assembled, the integrity of the user request message is confirmed, a result indicator as to the legitimacy of the resource provider message is created by performing two or more authenticity checks, and an authentication result is sent.
    Type: Application
    Filed: December 21, 2017
    Publication date: May 3, 2018
    Inventor: Jacques Noel Marc Chester
  • Patent number: 9853964
    Abstract: A method of authenticating the legitimacy of a request for a resource from a resource provider by a user, including providing an authentication process in which a resource provider message is received and de-assembled, the integrity of the user request message is confirmed, a result indicator as to the legitimacy of the resource provider message is created by performing two or more authenticity checks, and an authentication result is sent.
    Type: Grant
    Filed: November 27, 2012
    Date of Patent: December 26, 2017
    Assignee: Robojar Pty Ltd
    Inventor: Jacques Noel Marc Chester
  • Publication number: 20160285861
    Abstract: A method of authenticating the legitimacy of a request for a resource from a resource provider by a user, including providing an authentication process in which a resource provider message is received and de-assembled, the integrity of the user request message is confirmed, a result indicator as to the legitimacy of the resource provider message is created by performing two or more authenticity checks, and an authentication result is sent.
    Type: Application
    Filed: November 27, 2012
    Publication date: September 29, 2016
    Inventor: Jacques Noel Marc Chester
  • Patent number: 8357659
    Abstract: The invention relates to the use of the peptide toxin APETx2 that blocks the ASIC3 cationic channels and that is derived from the Anthopleura elegantissima sea anemone, and to the use of the analogs and derivatives thereof as a drug, particularly as an analgesic pain associated with the activation of ASIC3 (Acid Sensing Ion Channel 3) channels, in particular pain occurring upon an inflammation and potentially upon any painful situation associated with tissue acidosis (ischemiae, fractures, hematoma, oedema, phlyctena, local infections, tissue lesions, ocular wounds, tumours, etc.).
    Type: Grant
    Filed: June 4, 2009
    Date of Patent: January 22, 2013
    Assignees: Centre National de la Recherche Scientifique-CNRS, Universite Nice Sophia Antipolis
    Inventors: Emmanuel Deval, Sylvie Diochot, Michel Lazdunski, Eric Lingueglia, Jacques Noel
  • Publication number: 20110152197
    Abstract: The invention relates to the use of the peptide toxin APETx2 that blocks the ASIC3 cationic channels and that is derived from the Anthopleura elegantissima sea anemone, and to the use of the analogs and derivatives thereof as a drug, particularly as an analgesic pain associated with the activation of ASIC3 (Acid Sensing Ion Channel 3) channels, in particular pain occurring upon an inflammation and potentially upon any painful situation associated with tissue acidosis (ischemiae, fractures, hematoma, oedema, phlyctena, local infections, tissue lesions, ocular wounds, tumours, etc.
    Type: Application
    Filed: June 4, 2009
    Publication date: June 23, 2011
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS-, UNIVERSITE NICE SOPHIA ANTIPOLIS
    Inventors: Emmanuel Deval, Sylvie Diochot, Michel Lazdunski, Eric Lingueglia, Jacques Noel
  • Patent number: 7524823
    Abstract: The present invention relates to new antibiotic macrolide compounds of the general formula I: with improved activity, to medicaments comprising such antibiotics, and to the use of such antibiotics for the treatment of infectious diseases, inflammatory diseases and human diseases or disorders which can be ameliorated by inhibition human phospdiesterases.
    Type: Grant
    Filed: May 8, 2006
    Date of Patent: April 28, 2009
    Assignee: Basilea Pharmaceutica AG
    Inventors: Johannes Laurenz Kellenberger, Stuart Robert Shapiro, Salima Mathews, Philippe Guerry, Pierre Jacques Noël Barbier
  • Publication number: 20080151106
    Abstract: This invention relates to a method, a device, a computer program and a computer program product for scan-rate conversion of an image signal, comprising interpolating between at least a first image area of a first image of said image signal and a second image area of a second image of said image signal to obtain at least one interpolated image area, extrapolating at least one image area of at least one image of said image signal to obtain at least one extrapolated image area, and mixing said at least one interpolated image area and said at least one extrapolated image area to obtain a mixed image area. Said step of mixing advantageously depends on the decision whether the image area that is to be interpolated and/or extrapolated is an occlusion area, and on the accuracy of at least one determined motion vector.
    Type: Application
    Filed: February 18, 2005
    Publication date: June 26, 2008
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS, N.V.
    Inventors: Reinout Jacques Noel Verburgh, Harold Benten
  • Patent number: 4853053
    Abstract: Method of welding two hollow ceramic half-components containing an organic binder whereby each half-component is first loaded into a die, the jointing planes of the two half-components are then brought into contact by bringing together the two dies, working pressure is thereafter applied to one of the half-components in a direction perpendicular to the jointing planes and vibration is simultaneously applied to the other half-component in a direction parallel to the jointing planes to effect the welding of the two half-components by interpenetration. The two dies are then separated and the joined monobloc component is removed and sintered without altering the component's monolithic quality.
    Type: Grant
    Filed: November 30, 1987
    Date of Patent: August 1, 1989
    Assignee: Societe Anonyme Dite: Ceraver
    Inventors: Louis Minjolle, Michel Drouet, Jean-Louis Fatta-Barou, Michel Callegari, Jacques Noel
  • Patent number: 4781056
    Abstract: An optical device and method for strain detection. The device is provided with at least one optical fiber arranged so as to form a network. A light emitting device is arranged at one end of the fiber and a receiver is arranged at the other end, enabling the generation of information relative to the light intensity transmitted by the fiber or fibers in the presence of strain, and a measurement corresponding to the strain.
    Type: Grant
    Filed: November 7, 1986
    Date of Patent: November 1, 1988
    Assignee: Sopha Praxis
    Inventors: Jacques Noel, Jean-Claude Bocquet
  • Patent number: D312189
    Type: Grant
    Filed: January 23, 1987
    Date of Patent: November 20, 1990
    Assignee: Pillivuyt S.A.
    Inventor: Jacques Noel